Additive manufacturing enables the fabrication of patient-specific zirconia devices with integrated surface features; however, the biological effects of meso-scale topographies remain insufficiently understood. This in vitro study evaluated the influence of defined meso-scale surface modifications on osteoblast behavior using Digital Light Processing (DLP)-fabricated 3Y tetragonal zirconia polycrystal (3Y-TZP) and 5Y partially stabilized zirconia (5Y-PSZ). Planar control specimens and surfaces incorporating regularly distributed columnar structures (height: 100 µm; width: 40 µm; center-to-center spacing: 80, 120, and 160 µm; Mod-80, Mod-120, Mod-160) were fabricated and characterized after sintering. Cytotoxicity was assessed by elution testing and showed cell viability >98% for all groups. Osteoblast adhesion and proliferation (hFOB 1.19) were quantified using metabolic assays. Meso-scale modifications significantly increased early cell adhesion compared to planar controls (p 0.05). Osteogenic differentiation was evaluated by RT-qPCR (RUNX2, ALPL, COL1A1, BGLAP), revealing material- and geometry-dependent responses. On 3Y-TZP, meso-scale structures, particularly Mod-160, were associated with sustained upregulation of BGLAP, whereas 5Y-PSZ exhibited less pronounced effects. Within the limitations of this in vitro study, meso-scale surface structuring of additively manufactured zirconia enhances early osteoblast adhesion without affecting proliferation and may influence osteogenic differentiation in a material-dependent manner.
Hetzler et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: